Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026)

MoonLake Immunotherapeutics' Tax Rate history spans 6 years, with the latest figure at 0.9% for Q1 2026.

  • Quarterly Tax Rate fell 52.0% to 0.9% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.42% through Mar 2026, down 17.0% year-over-year, with the annual reading at 0.27% for FY2025, 3.0% down from the prior year.
  • Tax Rate came in at 0.9% for Q1 2026, down from 0.4% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.05% in Q1 2022 to a low of 0.9% in Q1 2026.
  • The 5-year median for Tax Rate is 0.17% (2025), against an average of 0.26%.
  • Year-over-year, Tax Rate skyrocketed 47bps in 2024 and then tumbled -52bps in 2026.
  • MoonLake Immunotherapeutics' Tax Rate stood at 0.07% in 2022, then tumbled by -737bps to 0.56% in 2023, then soared by 84bps to 0.09% in 2024, then plummeted by -347bps to 0.4% in 2025, then crashed by -128bps to 0.9% in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Tax Rate are 0.9% (Q1 2026), 0.4% (Q4 2025), and 0.16% (Q3 2025).